March 31, 2026
ABK Biomedical and MURR forge long-term partnership to advance breakthrough cancer therapy
A new agreement names MURR as the primary irradiation partner for ABK Biomedical's Eye90 microspheres.
March 24, 2026
DOE and MURR secure critical radioisotope supply chain for medical imaging
The University of Missouri Research Reactor is now the only domestic supplier of gadolinium-153 through a new agreement with the Department of Energy.
March 18, 2026
NextGen MURR teams with Burns & McDonnell, supporting the future of lifesaving nuclear medical isotope production
The drive to build a new state-of-the-art research reactor at Mizzou continues as a major milestone is reached.
March 9, 2026
MURR makes NCA Lu-177 available worldwide
Expanded supply will enable researchers and industry to purchase GMP no-carrier-added Lutetium-177 directly from the reactor.
Feb. 9, 2026
University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device
The clinical trial marks the latest human trial at Mizzou involving radioisotopes to treat cancer.
Jan. 26, 2026
Investigating sickle cell disease with SNMMI grant
A new imaging agent may reveal the causes of pain in sickle cell disease.
Jan. 7, 2026
Polarized Neutron Beam back at MURR after three decades
Oct. 28, 2025
University leaders and Korean alumni convene for 16th Harry S. Truman Conference
The Missouri delegation also toured leading engineering and energy facilities.
Sep. 4, 2025
University of Missouri continues to grow cancer-fighting drug production
Two new additions to the University of Missouri Research Reactor will streamline operations and greatly increase the number of cancer-fighting drug doses for patient care.
Aug. 11, 2025
DOE, the state of Missouri and Mizzou collaborate to address strategic radioisotopes in short supply
A new grant from the Department of Energy’s Office of Isotope R&D and Production, within the Office of Science, will help establish the Radioisotope Science Center to advance research, development, production, processing and distribution of nationally strategic radioisotopes in limited supply.